Print Page  Close Window

SEC Filings

OREXIGEN THERAPEUTICS, INC. filed this Form 8-K on 07/31/2018
Entire Document


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Date: July 31, 2018     By:  

/s/ Thomas P. Lynch

    Name:   Thomas P. Lynch
    Title:   Chief Administrative Officer, General Counsel, President, Secretary and Treasurer